e-learning
resources
Berlin 2008
Monday, 06.10.2008
Best of lung epithelial cells 2008
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Azithromycin protects bronchial epithelial integrity after
Pseudomonas aeruginosa
infection independent of bactericidal activity
S. Halldórsson, T. Guðjónsson, M. Gottfreðsson, G. H. Guðmundsson, O. Baldursson (Reykjavík, Iceland)
Source:
Annual Congress 2008 - Best of lung epithelial cells 2008
Session:
Best of lung epithelial cells 2008
Session type:
Oral Presentation
Number:
1762
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Halldórsson, T. Guðjónsson, M. Gottfreðsson, G. H. Guðmundsson, O. Baldursson (Reykjavík, Iceland). Azithromycin protects bronchial epithelial integrity after
Pseudomonas aeruginosa
infection independent of bactericidal activity. Eur Respir J 2008; 32: Suppl. 52, 1762
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Streptococcus pneumoniae inhibits Pseudomonas aeruginosa growth on nasal human epithelium in vitro
Source: International Congress 2018 – New therapies for respiratory infections: experimental and translational studies
Year: 2018
Exploring the susceptibility of P. aeruginosa biofilms in human mucus towards tobramycin treatment
Source: International Congress 2017 – Cystic fibrosis: clinical issues
Year: 2017
Human airway epithelial cell response to
Pseudomonas aeruginosa
virulence factors preceded or not by
Staphylococcus aureus
Source: Eur Respir J 2006; 28: Suppl. 50, 191s
Year: 2006
The effect of erythromycin on the chronic lower airway infection by pseudomonas aeruginosa
Source: Eur Respir J 2004; 24: Suppl. 48, 640s
Year: 2004
Three-dimensional lung epithelial cells potentiate aminoglycoside efficacy by enhancing intracellular pH in Pseudomonas aeruginosa
Source: International Congress 2018 – Mechanisms of respiratory infection
Year: 2018
The antimicrobial molecule elafin protects the lung against
Staphylococcus aureus
infection
Source: Annual Congress 2004 - Community acquired pneumonia - epidemiology and host defence
Year: 2004
Pseudomonas aeruginosa influences the inflammatory response of primary bronchial epithelial cells to rhinovirus infection
Source: Virtual Congress 2020 – Advances in cystic fibrosis: from microbiome to MRI
Year: 2020
Biofilm production and adherence to airway epithelial cells of
P. aeruginosa
strains: effect of N-acetyl-cysteine
Source: Eur Respir J 2005; 26: Suppl. 49, 726s
Year: 2005
Effects of erythromycin on Pseudomonas aeruginosa adherence to collagen and morphology in vitro
Source: Eur Respir J 2003; 21: 401-406
Year: 2003
Inhibitory activity of azithromycin on pseudomonas aeruginosa in biofilms
Source: Eur Respir J 2003; 22: Suppl. 45, 450s
Year: 2003
Effects of direct lung dosing of Tobramycin in a rat chronic infection model using Pseudomonas aeruginosa RP73
Source: International Congress 2018 – Mechanisms of respiratory infection
Year: 2018
ExoU-induced procoagulant activity in Pseudomonas aeruginosa-infected airway cells
Source: Eur Respir J 2008; 32: 1591-1598
Year: 2008
In vitro activity of colistin in combination with N-acetylcysteine against Pseudomonas aeruginosa
Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research
Year: 2018
Intracellular accumulation and bactericidal activity of moxifloxacin and ciprofloxacin in primary respiratory epithelial cells
Source: Eur Respir J 2002; 20: Suppl. 38, 91s
Year: 2002
Pseudomonas aeruginosa LasB subverts innate immunity in alveolar macrophages and epithelial cells
Source: International Congress 2018 – Disease exacerbations from a molecular point of view
Year: 2018
Adherence of
Pseudomonas aeruginosa
to cystic fibrosis buccal epithelial cells
Source: ERJ Open Res, 3 (1) 00095-2016; 10.1183/23120541.00095-2016
Year: 2017
The effect of clarithromycin on immunity of mice with chronic respiratory infection caused by
P. aeruginosa
Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi
Year: 2008
The role of ceramide in the host defense against
pseudomonas aeruginosa
infection
Source: Eur Respir J 2006; 28: Suppl. 50, 486s
Year: 2006
Effect of anti-PcrV antibody in a murine chronic airway Pseudomonas aeruginosa infection model
Source: Eur Respir J 2007; 29: 965-968
Year: 2007
Immunomodulatory properties of macrolide antibiotics in the treatment of bronchial sepsis involving
P. aeruginosa
Source: Eur Respir J 2004; 24: Suppl. 48, 639s
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept